Reversibility of Diffusion-Weighted Imaging Lesions in Patients With Ischemic Stroke in the WAKE-UP Trial

Author:

Scheldeman Lauranne123ORCID,Wouters Anke1234ORCID,Bertels Jeroen53ORCID,Dupont Patrick67ORCID,Cheng Bastian8ORCID,Ebinger Martin910ORCID,Endres Matthias11121314ORCID,Fiebach Jochen B.9ORCID,Gerloff Christian8ORCID,Muir Keith W.15,Nighoghossian Norbert16ORCID,Pedraza Salvador17ORCID,Simonsen Claus Z.18ORCID,Thijs Vincent1920ORCID,Thomalla Götz8ORCID,Lemmens Robin123ORCID

Affiliation:

1. Department of Neurology, University Hospitals Leuven, Belgium (L.S., A.W., R.L.).

2. Department of Neurosciences, Experimental Neurology KU Leuven (L.S., A.W., R.L.), University of Leuven, Belgium.

3. Center for Brain and Disease Research, Laboratory of Neurobiology, VIB, Leuven, Belgium (L.S., A.W., R.L., J.B.).

4. Department of Neurology, Amsterdam University Medical Centers, the Netherlands (A.W.).

5. Processing Speech and Images, Department of Electrial Engineering (J.B.), University of Leuven, Belgium.

6. Department of Neurosciences, Laboratory for Cognitive Neurology KU Leuven (P.D.), University of Leuven, Belgium.

7. Leuven Brain Institute, Belgium (P.D.).

8. Klinik und Poliklinik für Neurologie, Kopf- und Neurozentrum, University Medical Center Hamburg-Eppendorf, Germany (B.C., C.G., G.T.).

9. Center for Stroke Research Berlin (CSB) Charit. – Universit.tsmedizin Berlin, Germany (M. Ebinger, M. Endres, J.B.F.).

10. Klinik für Neurologie, Medical Park Berlin Humboldtmühle, Germany (M. Ebinger).

11. Klinik und Hochschulambulanz für Neurologie, Charit. – Universit.tsmedizin Berlin, Germany (M. Endres).

12. German Center for Cardiovascular Research (DZHK), partner site Berlin (M. Endres).

13. German Center for Neurodegenerative Diseases (DZNE), partner site Berlin (M. Endres).

14. ExcellenceCluster NeuroCure (M. Endres).

15. School of Psychology & Neuroscience, University of Glasgow, United Kingdom (K.W.M.).

16. Department of Stroke Medicine, Universit. Claude Bernard Lyon 1, CREATIS CNRS UMR 5220-INSERM U1206, INSA- Lyon, Hospices Civils de Lyon, France (N.N.).

17. Department of Radiology, Institut de Diagnostic per la Image (IDI), Hospital Dr Josep Trueta, Institut d’Investigaci. Biomedica de Girona (IDIBGI), Parc Hospitalari Marti i Julia de Salt – Edifici M2, Girona, Spain (S.P.).

18. Department of Neurology, Aarhus University Hospital, Denmark (C.Z.S.).

19. Stroke Theme, Florey Institute of Neuroscience and Mental Health, University of Melbourne, Heidelberg, Victoria, Australia (V.T.).

20. Department of Neurology, Austin Health, Heidelberg, Victoria, Australia (V.T.).

Abstract

Background: Reversibility of the diffusion-weighted imaging (DWI) lesion means that not all of the DWI lesion represents permanently injured tissue. We investigated DWI reversibility and the association with thrombolysis, reperfusion and functional outcome in patients from the WAKE-UP trial (Efficacy and Safety of Magnetic Resonance Imaging–Based Thrombolysis in Wake-Up Stroke). Methods: In this retrospective analysis of WAKE-UP, a randomized controlled trial (RCT) between September 2012 and June 2017 in Belgium, Denmark, France, Germany, Spain and United Kingdom, a convolutional neural network segmented the DWI lesions (b=1000 s/mm 2 ) at baseline and follow-up (24 hours). We calculated absolute and relative DWI reversibility in 2 ways: first, a volumetric (baseline volume−24-hour volume >0) and second, a voxel-based (part of baseline lesion not overlapping with 24-hour lesion) approach. We additionally defined relative voxel-based DWI-reversibility >50% to account for coregistration inaccuracies. We calculated the odds ratio for reversibility according to treatment arm. We analyzed the association of reversibility with excellent functional outcome (modified Rankin Scale score of 0–1), in a multivariable model. Results: In 363 patients, the median DWI volume was 3 (1–10) mL at baseline and 6 (2–20) mL at follow-up. Volumetric DWI reversibility was present in 19% (69/363) with a median absolute reversible volume of 1 mL (0–2) or 28% (14–50) relatively. Voxel-based DWI reversibility was present in 358/363 (99%) with a median absolute volume of 1 mL (0–2), or 22% (9–38) relatively. In 18% of the patients (67/363), relative voxel-based DWI reversibility >50% was present. Volumetric DWI reversibility and relative voxel-based DWI reversibility >50% was more frequent in patients treated with alteplase versus placebo (OR, 1.86 [95% CI, 1.09–3.17] and OR, 2.03 [95% CI, 1.18–3.50], respectively). Relative voxel-based DWI reversibility >50% was associated with excellent functional outcome (OR, 2.30 [95% CI, 1.17–4.51]). Conclusions: Small absolute volumes of DWI reversibility were present in a large proportion of randomized patients in the WAKE-UP trial. Reversibility was more often present after thrombolysis.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialized Nursing,Cardiology and Cardiovascular Medicine,Neurology (clinical)

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3